These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1684974)

  • 1. Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale.
    Sullivan JT; Swift RM; Lewis DC
    J Clin Psychopharmacol; 1991 Oct; 11(5):291-5. PubMed ID: 1684974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.
    DeCarolis DD; Rice KL; Ho L; Willenbring ML; Cassaro S
    Pharmacotherapy; 2007 Apr; 27(4):510-8. PubMed ID: 17381377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective review and assessment of benzodiazepines in the treatment of alcohol withdrawal in hospitalized patients.
    Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1994; 14(5):572-8. PubMed ID: 7997390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the management of alcohol withdrawal syndrome.
    Newman JP; Terris DJ; Moore M
    Laryngoscope; 1995 Jan; 105(1):1-7. PubMed ID: 7837904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of age on the severity, course, and complications of alcohol withdrawal.
    Kraemer KL; Mayo-Smith MF; Calkins DR
    Arch Intern Med; 1997 Oct; 157(19):2234-41. PubMed ID: 9343000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention.
    Longo LP; Campbell T; Hubatch S
    J Addict Dis; 2002; 21(2):55-64. PubMed ID: 11916372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of benzodiazepine guidelines in the management of patients hospitalized for alcohol withdrawal.
    Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1994; 14(5):579-85. PubMed ID: 7997391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol withdrawal prophylaxis in patients undergoing surgical treatment of head and neck squamous cell carcinoma.
    Neyman KM; Gourin CG; Terris DJ
    Laryngoscope; 2005 May; 115(5):786-90. PubMed ID: 15867640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines.
    Br Med J; 1980 Mar; 280(6218):910-2. PubMed ID: 7388368
    [No Abstract]   [Full Text] [Related]  

  • 14. Detoxification for triazolam physical dependence.
    Sullivan JT; Sellers EM
    J Clin Psychopharmacol; 1992 Apr; 12(2):124-7. PubMed ID: 1315343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.
    Prescrire Int; 2007 Feb; 16(87):24-31. PubMed ID: 17323538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol withdrawal syndrome.
    Landers DF
    Am Fam Physician; 1983 May; 27(5):114-8. PubMed ID: 6133441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of diazepam loading in the treatment of alcohol withdrawal among psychiatric inpatients.
    Salloum IM; Cornelius JR; Daley DC; Thase ME
    Psychopharmacol Bull; 1995; 31(2):305-10. PubMed ID: 7491383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
    Martin WR; Sloan JW; Wala E
    J Pharmacol Exp Ther; 1990 Nov; 255(2):744-55. PubMed ID: 1978731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.